193 related articles for article (PubMed ID: 31044478)
1. Variation of clinical manifestations according to culprit drugs in DRESS syndrome.
Sim DW; Yu JE; Jeong J; Jung JW; Kang HR; Kang DY; Ye YM; Jee YK; Kim S; Park JW; Kang MG; Kim SH; Park HK; Yang MS; Hur GY; Lee JK; Choi JH; Kwon YE; Koh YI;
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):840-848. PubMed ID: 31044478
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
[TBL] [Abstract][Full Text] [Related]
3. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
[TBL] [Abstract][Full Text] [Related]
4. DRESS characteristics according to the causative medication.
Chaabane A; Romdhane HB; Fadhel NB; Fredj NB; Ammar H; Boughattas N; Chadly Z; Aouam K
Eur J Clin Pharmacol; 2022 Sep; 78(9):1503-1510. PubMed ID: 35726027
[TBL] [Abstract][Full Text] [Related]
5. DRESS Syndrome Caused by Cross-reactivity Between Vancomycin and Subsequent Teicoplanin Administration: A Case Report.
Miyazu D; Kodama N; Yamashita D; Tanaka H; Inoue S; Imakyure O; Hirakawa M; Shuto H; Kataoka Y
Am J Case Rep; 2016 Aug; 17():625-31. PubMed ID: 27572807
[TBL] [Abstract][Full Text] [Related]
6. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH; Sekula P; Valeyrie-Allanore L; Liss Y; Chu CY; Creamer D; Sidoroff A; Naldi L; Mockenhaupt M; Roujeau JC;
Br J Dermatol; 2013 Nov; 169(5):1071-80. PubMed ID: 23855313
[TBL] [Abstract][Full Text] [Related]
7. DRESS Syndrome.
Jain P; Garg S; Sharma VK; Maheshwari S
J Assoc Physicians India; 2019 Apr; 67(4):87-88. PubMed ID: 31299851
[TBL] [Abstract][Full Text] [Related]
8. A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea.
Kang DY; Yun J; Lee SY; Koh YI; Sim DW; Kim S; Nam YH; Park JW; Kim SH; Ye YM; Park HK; Kim MH; Jee YK; Jung JW; Yang MS; Kim SH; Lee JK; Kim CW; Hur GY; Kim MY; Park SJ; Kwon YE; Choi JH; Kim JH; Kim SH; La HO; Kang MG; Park CS; Lee SM; Jeong YY; Kim HK; Jin HJ; Jeong JW; Lee J; Lee YW; Lee SE; Kim MS; Kang HR;
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):929-936.e7. PubMed ID: 32961314
[TBL] [Abstract][Full Text] [Related]
9. Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.
Del Pozzo-Magaña BR; Rieder MJ; Garcia-Bournissen F; Lazo-Langner A
Br J Clin Pharmacol; 2022 Sep; 88(9):4134-4141. PubMed ID: 35421262
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of DRESS Syndrome in the Elderly: A Comparative Study of 55 Patients.
Bahloul E; Trimeche K; Sellami K; Hammami F; Hayder F; Chaabouni R; Amouri M; Masmoudi A; Mseddi M; Boudeya S; Turki H
Dermatitis; 2024; 35(1):55-60. PubMed ID: 37669109
[No Abstract] [Full Text] [Related]
11. Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review.
Taweesedt PT; Nordstrom CW; Stoeckel J; Dumic I
Biomed Res Int; 2019; 2019():7863815. PubMed ID: 31662996
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
13. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
[TBL] [Abstract][Full Text] [Related]
14. Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution.
Sasidharanpillai S; Riyaz N; Rajan U; Binitha MP; Khader A; Mariyath OK; John R; Puravoor J
Indian J Dermatol Venereol Leprol; 2014; 80(3):221-8. PubMed ID: 24823399
[TBL] [Abstract][Full Text] [Related]
15. DRESS syndrome: a detailed insight.
Behera SK; Das S; Xavier AS; Selvarajan S
Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine-induced DRESS Syndrome: A Rare Delayed Hypersensitivity Reaction.
Hou WS; Tsai JP; Chiu YH; Lu ML
J Psychiatr Pract; 2022 Mar; 28(2):166-169. PubMed ID: 35238828
[TBL] [Abstract][Full Text] [Related]
17. Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients.
Sultan SJ; Sameem F; Ashraf M
Int J Dermatol; 2015; 54(5):537-42. PubMed ID: 24738653
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment.
Cabañas R; Calderón O; Ramírez E; Fiandor A; Caballero T; Heredia R; Herranz P; Madero R; Quirce S; Bellón T
Clin Exp Allergy; 2018 Mar; 48(3):325-333. PubMed ID: 29265576
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of add-on therapy with intravenous immunoglobulin in steroid hyporesponsive DRESS syndrome.
Sim DW; Yu J; Koh YI
Clin Transl Sci; 2022 Mar; 15(3):782-788. PubMed ID: 34796665
[TBL] [Abstract][Full Text] [Related]
20. Skin manifestations and clinical features of drug reaction with eosinophilia and systemic symptoms: a retrospective multicentre study of 125 patients.
Lee JW; Lee SR; Kim MJ; Cho S; Youn SW; Yang MS; Kim SH; Kang HR; Kwon O
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1584-1592. PubMed ID: 35342995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
